Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chappell

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Influenza and Other Respiratory Viruses|November 4, 2024
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Effectiveness of 2024-2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes - IVY Network, 26 Hospitals, September 1, 2024-April 30, 2025Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Pageof 25